Respiratory Muscle Training Program in Patients With Multiple Sclerosi

Pilot Experimental Study on the Impact of a Respiratory Muscle Training Program in Patients With Multiple Sclerosis

CompletedNot a drug-phase studyMS (type not specified)NCT06405451

What it found

Paper found, not read

A paper reports the results; we have not read it yet. See Papers below.

What was tested

Treatment tested

  • Experimental treatment

Given to everyone in the trial

  • Conventional treatment

What it measured

Main measures

  • Pulmonary function

    2 months

  • Respiratory muscle strength

    2 months

    Physical functionNerve conduction tests

  • Abdominal and diaphragmatic muscle structure

    2 months

    Brain volume loss

  • Trunk control

    2 months

    Walking and mobility

  • Balance

    2 months

    Walking and mobility

  • Gait and transfer capacity

    2 months

    Walking and mobility

Other measures (1)

  • Therapeutic adherence

    2 months

    Quality of life (reported by participants)

Who could take part

MS (type not specified) · 18 to 70

Show the full criteria

Inclusion criteria

* Confirmed diagnosis of Multiple Sclerosis based on McDonald criteria, with a disease duration of more than two years (relapsing or progressive) (McDonald et al., 2001). * All multiple sclerosis patients are included according to the Kurtzke Disability Status Scale (EDSS) ANEX II (Kurtzke 1983, Tollár 2020).* * Stable medical treatment for at least the six months prior to the intervention (Tollár, 2020). * Absence of cognitive impairment, with the ability to understand instructions and achieve a score equal to or greater than 24 on the Mini-Mental State Examination (Folstein, Folstein \& McHugh, 1975, Tollár 2020).

Exclusion criteria

* Diagnosis of another neurological disease or musculoskeletal alteration other than MS. * Diagnosis of any cardiovascular, respiratory, or metabolic disease, or other conditions that may interfere with this study. * Experienced exacerbation or hospitalization within the last 3 months prior to initiating the assessment protocol, nor during the therapeutic intervention process. * Received a cycle of steroids, intravenously or orally, 6 months prior to the start of the assessment protocol and within the study intervention period.

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

This is a quasi-experimental pre-post trial aimed at investigating the effects of respiratory muscle training (RMT) as trunk stabilization exercise in patients diagnosed with multiple sclerosis (MS)

Papers

Loading reviews and guidelines…

History

    1. Started

      Apr 2024

    2. Main results due

      Jul 2024

    3. Finished

      Dec 2024

    Assembled by software from public sources.